VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

BioCardia, Inc. (BCDA) Total Return Calculator with Dividends Reinvested

BioCardia, Inc.

Popular:

The total return for BioCardia, Inc. (BCDA) stock is -58.87% over the past 12 months. So far it's down 14.17% this year. The 5-year total return is -99.30%, meaning $10,000 invested in BCDA stock 5 years ago would be worth $70 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in BCDA 1 year ago, it would be worth $3,825 today — you'd have lost $6,175.

With Dividends Reinvested$3,825-61.75%

Price Only (No DRIP)$3,825-61.75%

Period2025-05-08 → 2026-05-07

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in BCDA

1Y$4,113-$5,887 (-58.9%)-58.9% CAGR

3Y$119-$9,881 (-98.8%)-77.2% CAGR

5Y$70-$9,930 (-99.3%)-62.9% CAGR

10Y$28-$9,972 (-99.7%)-44.4% CAGR

15Y$56-$9,944 (-99.4%)-29.2% CAGR

20Y$1-$9,999 (-100.0%)-36.5% CAGR

30Y$0-$10,000 (-100.0%)-34.6% CAGR

BioCardia, Inc. did not pay dividends during this period. Total return = price return.

Loading BCDA total return...

As of 2026-05-08

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	-14.17%	—	-14.17%	—	$8,583
1Y	-58.87%	-58.87%	-58.87%	—	$4,113
3Y	-98.81%	-77.19%	-98.81%	—	$119
5Y	-99.30%	-62.91%	-99.30%	—	$70
10Y	-99.72%	-44.44%	-99.72%	—	$28
15Y	-99.44%	-29.22%	-99.44%	—	$56
20Y	-99.99%	-36.46%	-99.99%	—	$1
30Y	-100.00%	-34.55%	-100.00%	—	$0

Risk & Highlights

Best Year+1250.54%2016

Worst Year-94.59%2010

Max Drawdown-61.75%2025-05-09 → 2026-02-04

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	+1.57%	+1.57%	—	+0.41%	+1.2pp
2025	-44.69%	-44.69%	—	+16.64%	-61.3pp
2024	-78.07%	-78.07%	—	+24.00%	-102.1pp
2023	-89.80%	-89.80%	—	+24.81%	-114.6pp
2022	+5.03%	+5.03%	—	-19.95%	+25.0pp

BCDA underperformed the S&P 500 by 89.24pp over the past year (-58.87% vs +30.37%).

Loading summary...

BCDA Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
BCDABioCardia, Inc.	$5M	-8.4%	-14.2%	-58.9%	—	-98.8%	-99.3%	-99.7%
MCRBSeres Therapeutics, Inc.	$74M	-12.8%	-49.0%	-6.9%	—	-93.1%	-98.1%	-98.5%
ANIKAnika Therapeutics, Inc.	$203M	+1.5%	+61.9%	+4.5%	—	-41.7%	-63.9%	-65.9%
NVCRNovoCure Limited	$1.9B	+62.6%	+28.3%	+1.1%	—	-75.7%	-91.3%	+30.3%
ADMAADMA Biologics, Inc.	$2.0B	-8.5%	-52.6%	-64.1%	—	+142.0%	+386.8%	+39.8%
VCELVericel Corporation	$1.8B	+5.4%	-1.3%	-13.2%	—	+6.5%	-33.3%	+1205.9%
FATEFate Therapeutics, Inc.	$280M	+111.3%	+145.5%	+143.0%	—	-55.4%	-96.8%	+40.5%
MDXGMiMedx Group, Inc.	$548M	-4.4%	-43.1%	-47.1%	—	-36.6%	-62.9%	-48.5%
RGENRepligen Corporation	$7.1B	+9.7%	-23.1%	-0.4%	—	-19.3%	-32.7%	+369.1%
CYTKCytokinetics, Incorporated	$9.1B	+13.5%	+20.3%	+124.8%	—	+93.4%	+206.6%	+817.2%
BSXBoston Scientific Corporation	$84.1B	-8.5%	-40.3%	-46.0%	—	+6.5%	+31.2%	+155.5%

Compare:BCDA vs MCRB BCDA vs ANIK BCDA vs NVCR BCDA vs MCRB vs ANIK

About BCDA Dividend Returns

BioCardia, Inc. (BCDA) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of BCDA over the past year?

BioCardia, Inc. (BCDA) delivered a return of -58.87% over the past year. Since BCDA does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in BCDA be worth today?

A $10,000 investment in BioCardia, Inc. one year ago would be worth $4,113 today, representing a loss of $5,887.

Q3Does BCDA pay dividends?

BioCardia, Inc. (BCDA) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For BCDA, the total return equals the price-only return.

Q4Did BCDA beat the S&P 500?

No, BioCardia, Inc. (BCDA) underperformed the S&P 500 by 89.24 percentage points over the past year. BCDA delivered a total return of -58.87%, compared to the S&P 500's 30.37%. This means a passive S&P 500 index fund outperformed BCDA by 89.24pp during this period.

Q5What is BCDA's worst drawdown?

BioCardia, Inc. (BCDA) experienced a maximum drawdown of -61.75% over the past year, declining from its peak on 2025-05-09 to its trough on 2026-02-04. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is BCDA's long-term total return over 10, 20, or 30 years?

Here are BioCardia, Inc. (BCDA)'s long-term returns with dividends reinvested. Over 10 years, the total return is -99.7% (-44.4% CAGR) — $10,000 would have grown to $28. Over 20 years: -100.0% total return (-36.5% CAGR) — $10,000 → $1. Over 30 years: -100.0% total return (-34.6% CAGR) — $10,000 → $0. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was BCDA's best and worst year?

BioCardia, Inc.'s best calendar year was 2016 with a total return of 1250.5%. Its worst year was 2010 with a total return of -94.6%. This range shows the volatility investors should expect — the difference between the best and worst year is 1345.1 percentage points.